Environmental, Social And Governance (ESG) Performance Report

Overview

The report covers EyePoint Pharmaceuticals' 2023 ESG activities, highlighting the launch of the company-wide Envision Our Future employee-engagement initiative and a new Clinical Trial / Research Standards Policy. It describes zero work-related injuries, illnesses and fatalities, alongside employee inclusion, engagement and development programs. The report also outlines a new supplier audit program and a planned Northbridge manufacturing facility incorporating 28 ESG-centric elements across water, energy, emissions reduction and construction. Board oversight of ESG policies, goals and initiatives is explicitly described.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services